A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications.
Saved in:
| Title: | A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications. |
|---|---|
| Authors: | Pozo-Rosich, Patricia1 (AUTHOR) patricia.pozo@vhir.org, López, José Antonio Gien2 (AUTHOR), Lisewski, Pawel3 (AUTHOR), Aslan, Ayşe Neslihan4 (AUTHOR), Seehra, Harpreet5 (AUTHOR), Thiry, Alexandra6 (AUTHOR), Abraham, Lucy5 (AUTHOR), Ramirez, Luz M.7 (AUTHOR), Fountaine, Robert6 (AUTHOR), Fullerton, Terence6 (AUTHOR) |
| Source: | Cephalalgia. Nov2025, Vol. 45 Issue 11, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 03331024 |
|---|---|
| DOI: | 10.1177/03331024251391378 |
